ChemoMetec ASOCSE:CHEMM +0.76%99 OCF Margin % is 36.40% as of Dec. 2025, which is 9% above its 10-year median of 33.43. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 98.28% on this metric.
The historical rank and industry rank for ChemoMetec AS's OCF Margin % or its related term are showing as below:
OCSE:CHEMM'
s OCF Margin % Range Over the Past 10 Years
Min: 10.8 Med: 33.43 Max: 41.86
Current: 42.6
During the past 13 years, the highest OCF Margin % of ChemoMetec AS was 41.86%. The lowest was 10.80%. And the median was 33.43%.
OCSE:CHEMM's OCF Margin % is ranked better than 98.28% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs OCSE:CHEMM: 42.60
ChemoMetec AS OCF Margin % Related Terms
ChemoMetec AS OCF Margin % Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, ChemoMetec AS's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's OCF Margin % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a OCF Margin % of 36.40% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ChemoMetec AS and its competitors. This is near median its historical median of 33.43. Over the past decade, ChemoMetec AS's OCF Margin % has ranged from 10.80 to 41.86. According to the industry distribution chart, ChemoMetec AS ranks #14 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 1.7%.
Is ChemoMetec AS's OCF Margin % too high?
ChemoMetec AS's current OCF Margin % of 36.40% is near median its 10-year median of 33.43. Over the past 10 years, this metric has ranged from a low of 10.80 to a high of 41.86. The Medical Devices & Instruments industry median OCF Margin % is 5.86. ChemoMetec AS's value of 36.40% is 521.2% above this industry median. Based on the distribution chart, ChemoMetec AS ranks #14 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #14 out of 815 companies for OCF Margin %. This places ChemoMetec AS in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. ChemoMetec AS's value of 36.40% is 521.2% above this benchmark. Historically, ChemoMetec AS's own OCF Margin % has ranged from 10.80 to 41.86 over the past decade. While the company's 10-year median is 33.43 vs. the industry median of 5.86, ChemoMetec AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current OCF Margin % of 36.40% is 521.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current OCF Margin % is 36.40%, which is near median its own 10-year median of 33.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr369.20 — trading 29.5% below its estimated fair value. The current OCF Margin % is 36.40%, which is near median its 10-year median of 33.43 and 521.2% above the Medical Devices & Instruments industry median of 5.86. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current OCF Margin % is 36.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr369.20 is trading 29.5% below its estimated GF Value™ of kr523.33.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
OCF Margin %: 36.40% (near median its 10-year median of 33.43)
GF Value™: kr523.33 vs. price of kr369.20 (29.5% below fair value)
Industry Position: 521.2% above the Medical Devices & Instruments median (#14 of 815)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
